Latest Headlines

Latest Headlines

UCB to host epilepsy digital tool hackathon

UCB is hosting a hackathon focused on developing new tools to improve the day-to-day lives of people with epilepsy and their families, PMLiVE reports.

Medtronic prepares to head back to FDA with deep brain stimulation for epilepsy

Medtronic has published detailed results for the first time of a 5-year trial for deep brain stimulation therapy in treatment-resistant epilepsy. The device giant has said that it will make another run at an FDA approval for its DBS device in that indication.

Genetic trigger to rare type of epilepsy found at Scripps

Investigators at Scripps Translational Science Institute say they have identified the genetic trigger for a rare and potentially lethal form of epilepsy.

UPDATED: Boston Children's Hospital debuts 'Baby MEG' brain imaging system

Boston Children's Hospital has unveiled a new magnetoencephalography system that records, measures and maps electrical activity in an infant's brain which could be critical in understanding a number of disorders, including epilepsy.

Gene sequencing helps Northwestern team diagnose one cause of epilepsy

Researchers at Northwestern University's Feinberg School of Medicine used a form of gene sequencing to identify mutations that appear to be behind a type of epilepsy disorder.

Med tech IPOs for NeuroSigma, ReWalk ready for fall

Epilepsy devicemaker NeuroSigma filed to raise up to $50 million in an IPO, while ReWalk--whose mobile exoskeletons were recently approved by the FDA--set IPO terms to raise $50 million.

UPDATED: NeuroPace RNS Stimulator secures add-on payments from CMS

NeuroPace's implantable neurostimulator will receive new technology add-on payments from the federal Centers for Medicare & Medicaid Services in recognition of its clinical benefits compared to older therapies for the treatment of uncontrolled epilepsy in adults. 

UCB inches toward the FDA with its latest epilepsy contender

A new epilepsy treatment from Belgian drugmaker UCB helped reduce the rate of seizures in a Phase III trial, the company said, setting the stage for an FDA application and a shot at widening its footprint in the field.

NeuroPace stimulator to be deployed in $40M DOD brain research initiative

The $40 million Department of Defense research program into restoring memory will use NeuroPace's implantable neurostimulator, a move that the company said could help it expand the product's indications beyond epilepsy.

Government awards $26M to study neural implants for Parkinson's

President Obama's Brain Initiative awarded millions to University of California researchers to develop mini brain implants that treat Parkinson's disease and epilepsy.